When Two Worlds Meet: Understanding AIH-PBC and AIH-PSC Overlap
At a Glance
An autoimmune liver overlap syndrome, such as AIH-PBC or AIH-PSC, is a single complex condition affecting both liver cells and bile ducts simultaneously. It requires specialized, dual-target treatment from an experienced hepatologist to prevent rapid progression to permanent liver scarring.
It is completely normal to feel overwhelmed if you have been told you have an “overlap syndrome.” Hearing that you have features of two different rare liver diseases can feel like a “double diagnosis.” However, in the world of hepatology, an overlap syndrome is not necessarily two separate diseases attacking at once; rather, it is a single autoimmune process that happens to affect two different parts of your liver: the liver cells (hepatocytes) and the bile ducts [1].
What is an Overlap Syndrome?
Most autoimmune liver diseases fall into one of two categories: those that attack the liver cells (Autoimmune Hepatitis or AIH) and those that attack the bile ducts (cholestatic diseases like PBC or PSC). An overlap syndrome occurs when your clinical “picture”—including blood tests, antibody markers, and liver biopsy—shows clear evidence of both [2][3].
- AIH-PBC Overlap: This is the most common form, where a patient has the inflammation characteristic of AIH alongside the bile duct damage seen in Primary Biliary Cholangitis (PBC) [2].
- AIH-PSC Overlap: This occurs when AIH features are found alongside Primary Sclerosing Cholangitis (PSC), a condition that causes scarring and narrowing of the bile ducts [4]. In children, this is often called Autoimmune Sclerosing Cholangitis (ASC) [5].
If you feel like your case is unique, you are partly right, but you are not alone. Research indicates that approximately 11% of patients with biopsy-proven autoimmune liver disease have an overlap of AIH and PBC [6].
Why This Diagnosis Matters
Doctors pay close attention to overlap syndromes because they can be more complex than a single disease alone.
- Disease Course: Patients with an overlap syndrome may face a faster progression toward cirrhosis (permanent liver scarring) compared to those with a single liver condition [7][8]. However, this is precisely why catching it is so important—proper treatment significantly reduces this risk.
- Dual Target: Because the disease affects two different types of tissue, it requires a “two-pronged” management strategy to protect both your liver cells and your bile ducts [9].
Vetting Your Specialist
Because these conditions are rare and complex, finding the right doctor is the most important first step you can take. It is critical to work with a hepatologist (liver specialist), preferably one associated with a transplant center, who has experience specifically with overlap syndromes. Use the “Questions for your Doctor” on this page to help vet their expertise.
Navigating This Guide
This resource is designed to help you understand your diagnosis, manage your daily symptoms, and partner effectively with your medical team.
Biology, Diagnosis, and Your Pathology Report
Learn how to read your AIH-PBC or AIH-PSC overlap syndrome pathology report. Understand the Paris Criteria, interface hepatitis, and florid duct lesions.
Understanding the Subtypes: AIH-PBC vs. AIH-PSC Overlap
Learn the differences between AIH-PBC and AIH-PSC overlap syndromes. Understand the symptoms, risks like IBD or lupus, and how they progress over time.
The Path Forward: Standard of Care and Treatment Options
Learn about combination therapy for AIH-PBC and AIH-PSC overlap syndromes. Understand first-line treatments like UDCA and steroids and safety protocols.
Long-Term Monitoring and Cancer Surveillance
Learn the long-term monitoring and cancer screening schedule for AIH-PSC and AIH-PBC overlap syndromes. Understand MRCP, colonoscopy, and elastography tests.
Common questions in this guide
What is an autoimmune liver disease overlap syndrome?
How is an overlap syndrome different from having two separate liver diseases?
Why does an AIH-PBC or AIH-PSC overlap diagnosis require a specialized hepatologist?
What are the Paris criteria for autoimmune liver disease?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my labs and biopsy, do I meet the specific 'Paris criteria' for an overlap syndrome, or do I have a variant presentation?
- 2.How many patients with an autoimmune liver disease overlap syndrome do you currently manage in your practice?
- 3.What are the specific target numbers for my ALT, ALP, and IgG that would indicate my treatment is working?
- 4.Are you a transplant hepatologist, and is your practice affiliated with a larger transplant or academic medical center?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Autoimmune Hepatitis Overlap Syndromes and Liver Pathology.
Czaja AJ, Carpenter HA
Gastroenterology clinics of North America 2017; (46(2)):345-364 doi:10.1016/j.gtc.2017.01.008.
PMID: 28506369 - 2
Chronic Liver Disease, Not Everything Is What It Seems: Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome.
Rodrigues Barbosa B, Pereira L, Campante F, Pona AP
Cureus 2024; (16(1)):e51630 doi:10.7759/cureus.51630.
PMID: 38313999 - 3
Progress and Perspectives in Overlapping Primary Biliary Cholangitis and Autoimmune Hepatitis: A Comprehensive Review.
Qin X, Jin Z
Journal of gastrointestinal and liver diseases : JGLD 2025; (34(2)):241-249 doi:10.15403/jgld-6138.
PMID: 40580520 - 4
Autoimmune Disorders of the Liver and Biliary Tract.
Anderson CM, Welle CL, Ludwig DR, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(4)):e240126 doi:10.1148/rg.240126.
PMID: 40111901 - 5
Incidence and Clinical Features of Autoimmune Hepatitis in the Province of Santa Fe (Argentina).
Costaguta A, González A, Pochettino S, et al.
Journal of pediatric gastroenterology and nutrition 2018; (67(6)):e107-e110 doi:10.1097/MPG.0000000000002122.
PMID: 30095578 - 6
Prevalence and clinicopathological Spectrum of Auto-Immune Liver Diseases & Overlap syndrome.
Varadarajan A, Rastogi A, Maiwall R, et al.
Indian journal of pathology & microbiology 2024; (67(1)):107-114 doi:10.4103/ijpm.ijpm_72_22.
PMID: 38358198 - 7
Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
Martínez Casas OY, Díaz Ramírez GS, Marín Zuluaga JI, et al.
Gastroenterologia y hepatologia 2018; (41(9)):544-552 doi:10.1016/j.gastrohep.2018.05.019.
PMID: 30017212 - 8
Clinical outcomes in patients with autoimmune hepatitis and primary biliary cholangitis overlap syndrome in the United States.
Goyal RM, Bansal B, Ayyad M, et al.
Clinics and research in hepatology and gastroenterology 2025; (49(6)):102598 doi:10.1016/j.clinre.2025.102598.
PMID: 40294647 - 9
Fulminant Primary Biliary Cholangitis-Autoimmune Hepatitis (PBC-AIH) Overlap Syndrome in a 27-Year-Old Woman With Childhood-Onset AIH: Steroid-Refractory Decompensation Necessitating Urgent Transplant Evaluation.
Said E, Tafesse Y, Elbenawi HR, et al.
Cureus 2025; (17(7)):e87519 doi:10.7759/cureus.87519.
PMID: 40786261
This page provides an overview of AIH-PBC and AIH-PSC overlap syndromes for educational purposes. It is not a substitute for professional medical advice, diagnosis, or treatment from a qualified hepatologist.
Get notified when new evidence is published on Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.